In addition, another miRNA, miR-29a-3p, which proved complementarities to the 3-UTR of DNMT3A and 3B 51, exhibited a significant reduction in 90% of Egyptian AML patients52. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.